Insulin glargine and Risankizumab-rzaa topical
Determining the interaction of Insulin glargine and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Risedronate
- Insulin glargine-Risedronate and Calcium
- Insulin glargine-Risedronate Delayed Release
- Insulin glargine-Risedronate Delayed-Release Tablets
- Insulin glargine-Risedronate Sodium
- Insulin glargine-Risedronate Tablets
- Risankizumab-rzaa topical-Insulin Glargine (U-100) Cartridge Systems and Pens
- Risankizumab-rzaa topical-Insulin Glargine (U-100) Vials
- Risankizumab-rzaa topical-Insulin Glargine (U-300) Pens
- Risankizumab-rzaa topical-Insulin glargine and lixisenatide
- Risankizumab-rzaa topical-Insulin glargine and lixisenatide Subcutaneous
- Risankizumab-rzaa topical-Insulin glargine, recombinant Subcutaneous